Reuters is tracking how companies are responding to the threat posed by <a href=" target="_blank" rel="noopener noreferrer nofollow">U.S. President Donald Trump’s tariffs to their operations.

Trump says foreign nations pay U.S. tariffs, but American businesses report higher costs and supply issues—highlighting the real impact on companies and consumers.

President Trump announced his intent to impose tariffs on imported pharmaceuticals and semiconductors, which may reach 200%. This move aims to boost U.S. manufacturing, but has faced criticism from drugmakers fearing shortages and accessibility issues.